Holen Sie sich die Stockscreener-App
449.74
2.19%
-10.07
Handel nachbörslich:
447.35
-2.39
-0.53%
Finanzdaten der Madrigal Pharmaceuticals Inc-Aktie (MDGL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
17.00%
364.25
|
311.34 | 321.08 | 287.27 | 212.80 |
| Operating Expenses |
4.08%
420.56
|
404.06 | 380.69 | 401.24 | 260.00 |
| Operating Income/Loss |
39.27%
-56.31
|
-92.72 | -59.61 | -113.97 | -47.20 |
| Net Income/Loss |
38.62%
-57.94
|
-94.39 | -58.58 | -114.19 | -42.28 |
| Basic Average Shares |
0.39%
29.15
|
29.03 | 0.1726 | 22.48 | 22.21 |
| Diluted Average Shares |
0.39%
29.15
|
29.03 | 0.1726 | 22.48 | 22.21 |
| Basic Earnings Per Share |
38.77%
-1.99
|
-3.25 | -2.53 | -5.08 | -1.90 |
| Diluted Earnings Per Share |
38.77%
-1.99
|
-3.25 | -2.53 | -5.08 | -1.90 |
2.44%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):